
JNJ Stock Forecast & Price Target
JNJ Analyst Ratings
Bulls say
Johnson & Johnson is a well-diversified healthcare company with a strong focus on innovation and sustainability. With a strong financial position and a diverse management team, the company has potential for growth through M&A and product launches. However, there are also potential risks associated with pricing challenges and ongoing litigation.
Bears say
Johnson & Johnson is seeing strong top- and bottom-line growth, but the negative outlook is driven by concerns regarding the company's litigation risk related to talc products. Additionally, high levels of investment in new product launches could impact profitability in the short term. However, the company's strong position and leadership in the growing medtech industry could drive long-term growth potential.
This aggregate rating is based on analysts' research of Johnson & Johnson and is not a guaranteed prediction by Public.com or investment advice.
JNJ Analyst Forecast & Price Prediction
Start investing in JNJ
Order type
Buy in
Order amount
Est. shares
0 shares